1236033-21-8 Usage
General Description
Tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate is a chemical compound with a complex molecular structure that includes a tert-butyl group, a chloro group, and a pyrrolopyrimidine ring. tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate has potential applications in the pharmaceutical industry, particularly in the development of new drugs. Its specific chemical properties and structure make it of interest for medicinal and chemical research. As a carboxylate ester, it is also likely to be involved in chemical reactions that produce various derivatives and analogues for experimental and commercial purposes. Overall, the chemical properties and structure of tert-butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate make it a valuable compound for research and potential use in drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1236033-21-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,6,0,3 and 3 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1236033-21:
(9*1)+(8*2)+(7*3)+(6*6)+(5*0)+(4*3)+(3*3)+(2*2)+(1*1)=108
108 % 10 = 8
So 1236033-21-8 is a valid CAS Registry Number.
1236033-21-8Relevant articles and documents
Preparation method of key intermediate of JAK inhibitor
-
Paragraph 0064-0066, (2021/09/04)
The invention discloses a preparation method of a key intermediate of a JAK inhibitor. The preparation method comprises the following steps: step a, protecting an amino group of a raw material 4-chloro-7H-pyrrole-[2.3-d]-pyrimidine to synthesize 4-chloro-
Small molecular compound
-
Paragraph 0082-0086, (2020/10/29)
The invention provides a small molecular compound, which is characterized by being a compound shown as the following structure or pharmaceutically acceptable salt thereof, wherein G is a group with aromaticity; X is a nitrogen-containing group; R is a fluorine-containing group; and Cz is connected with a nitrogen atom in the X group. The related compounds have a good performing on inhibiting Jak kinase activity and cytobiological activity.
Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2
-
Page/Page column 152, (2018/11/21)
The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. For Formula I compounds A1, A2
